Ming‐Shi Chang

机构：National Cheng Kung University · ORCID：0000-0001-9577-0400

发表论文 110 篇 · 总被引 10806 次 · h-index 37

代表论文

• IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models (2020 · Nature Communications · 被引 89)
• Interleukin-20 is involved in dry eye disease and is a potential therapeutic target (2022 · Journal of Biomedical Science · 被引 68)
• Targeting interleukin-20 alleviates paclitaxel-induced peripheral neuropathy (2020 · Pain · 被引 40)
• Anti-IL-20 antibody improved motor function and reduced glial scar formation after traumatic spinal cord injury in rats (2020 · Journal of Neuroinflammation · 被引 34)
• Anti-IL-20 monoclonal antibody promotes bone fracture healing through regulating IL-20-mediated osteoblastogenesis (2016 · Scientific Reports · 被引 33)
• IL‐20 is involved in obesity by modulation of adipogenesis and macrophage dysregulation (2021 · Immunology · 被引 29)